152 related articles for article (PubMed ID: 38142245)
41. Programming Probiotics: Diet-Responsive Gene Expression and Colonization Control in Engineered
Durmusoglu D; Haller DJ; Al'Abri IS; Day K; Sands C; Clark A; San-Miguel A; Vazquez-Uribe R; Sommer MOA; Crook NC
ACS Synth Biol; 2024 Jun; 13(6):1851-1865. PubMed ID: 38787439
[No Abstract] [Full Text] [Related]
42. Saccharomyces cerevisiae fungemia: Risk factors, outcome and links with S. boulardii-containing probiotic administration.
Poncelet A; Ruelle L; Konopnicki D; Miendje Deyi VY; Dauby N
Infect Dis Now; 2021 May; 51(3):293-295. PubMed ID: 33934809
[TBL] [Abstract][Full Text] [Related]
43. Saccharomyces boulardii attenuates lipopolysaccharide-induced anxiety-like behaviors in rats.
Babaei F; Mirzababaei M; Mohammadi G; Dargahi L; Nassiri-Asl M
Neurosci Lett; 2022 May; 778():136600. PubMed ID: 35358641
[TBL] [Abstract][Full Text] [Related]
44. Fermented Momordica charantia L. juice modulates hyperglycemia, lipid profile, and gut microbiota in type 2 diabetic rats.
Gao H; Wen JJ; Hu JL; Nie QX; Chen HH; Xiong T; Nie SP; Xie MY
Food Res Int; 2019 Jul; 121():367-378. PubMed ID: 31108759
[TBL] [Abstract][Full Text] [Related]
45. Unique Probiotic Properties and Bioactive Metabolites of Saccharomyces boulardii.
Fu J; Liu J; Wen X; Zhang G; Cai J; Qiao Z; An Z; Zheng J; Li L
Probiotics Antimicrob Proteins; 2023 Aug; 15(4):967-982. PubMed ID: 35608794
[TBL] [Abstract][Full Text] [Related]
46. Molecular tools for differentiating probiotic and clinical strains of Saccharomyces cerevisiae.
Posteraro B; Sanguinetti M; Romano L; Torelli R; Novarese L; Fadda G
Int J Food Microbiol; 2005 Sep; 103(3):295-304. PubMed ID: 16099314
[TBL] [Abstract][Full Text] [Related]
47. Synergistic antidiabetic activity of Taraxacum officinale (L.) Weber ex F.H.Wigg and Momordica charantia L. polyherbal combination.
Perumal N; Nallappan M; Shohaimi S; Kassim NK; Tee TT; Cheah YH
Biomed Pharmacother; 2022 Jan; 145():112401. PubMed ID: 34785415
[TBL] [Abstract][Full Text] [Related]
48.
Yang Z; Wu Y; Liu X; Zhang M; Peng J; Wei H
Nutrients; 2022 Aug; 14(17):. PubMed ID: 36079743
[TBL] [Abstract][Full Text] [Related]
49. Preparation of
Shu G; Li B; Dai C; Chen L; Yang X; Lei Z; Zhang M; Guo Y
Prep Biochem Biotechnol; 2022; 52(9):1078-1086. PubMed ID: 35108154
[No Abstract] [Full Text] [Related]
50. Antioxidant properties and global metabolite screening of the probiotic yeast Saccharomyces cerevisiae var. boulardii.
Datta S; Timson DJ; Annapure US
J Sci Food Agric; 2017 Jul; 97(9):3039-3049. PubMed ID: 27868205
[TBL] [Abstract][Full Text] [Related]
51. Antidiabetic activity of Momordica charantia seeds on streptozotocin induced diabetic rats.
Sekar DS; Sivagnanam K; Subramanian S
Pharmazie; 2005 May; 60(5):383-7. PubMed ID: 15918591
[TBL] [Abstract][Full Text] [Related]
52. Oral Administration of Recombinant
Bagherpour G; Ghasemi H; Zand B; Zarei N; Roohvand F; Ardakani EM; Azizi M; Khalaj V
Front Microbiol; 2018; 9():723. PubMed ID: 29706942
[No Abstract] [Full Text] [Related]
53. Effects of broad-spectrum antibiotics on the colonisation of probiotic yeast Saccharomyces boulardii in the murine gastrointestinal tract.
Hedin KA; Rees VE; Zhang H; Kruse V; Vazquez-Uribe R; Sommer MOA
Sci Rep; 2022 May; 12(1):8862. PubMed ID: 35614092
[TBL] [Abstract][Full Text] [Related]
54. The Probiotic Effects of the
Lee JE; Lee E
J Microbiol Biotechnol; 2022 Jul; 32(7):877-884. PubMed ID: 35791078
[TBL] [Abstract][Full Text] [Related]
55. Health-promoting properties of
Ansari F; Alian Samakkhah S; Bahadori A; Jafari SM; Ziaee M; Khodayari MT; Pourjafar H
Crit Rev Food Sci Nutr; 2023; 63(4):457-485. PubMed ID: 34254862
[No Abstract] [Full Text] [Related]
56. Effects of
West C; Stanisz AM; Wong A; Kunze WA
World J Gastroenterol; 2016 Dec; 22(48):10532-10544. PubMed ID: 28082805
[TBL] [Abstract][Full Text] [Related]
57. Clinical Efficacy Comparison of Saccharomyces Boulardii and Lactic Acid as Probiotics in Acute Pediatric Diarrhea.
Asmat S; Shaukat F; Asmat R; Bakhat HFSG; Asmat TM
J Coll Physicians Surg Pak; 2018 Mar; 28(3):214-217. PubMed ID: 29544579
[TBL] [Abstract][Full Text] [Related]
58. Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae.
Edwards-Ingram L; Gitsham P; Burton N; Warhurst G; Clarke I; Hoyle D; Oliver SG; Stateva L
Appl Environ Microbiol; 2007 Apr; 73(8):2458-67. PubMed ID: 17293506
[TBL] [Abstract][Full Text] [Related]
59. Comparison of the effects of glibenclamide on metabolic parameters, GLUT1 expression, and liver injury in rats with severe and mild streptozotocin-induced diabetes mellitus.
Sokolovska J; Isajevs S; Sugoka O; Sharipova J; Paramonova N; Isajeva D; Rostoka E; Sjakste T; Kalvinsh I; Sjakste N
Medicina (Kaunas); 2012; 48(10):532-43. PubMed ID: 23324250
[TBL] [Abstract][Full Text] [Related]
60. Investigation of the effect of addition of Momordica charantia to glibenclamide on amelioration of endothelial dysfunction in diabetic rats by activating Takeda G protein-coupled receptor 5.
Idrees M; U Rahman I; A Khan H; M Yousufzai Y; H Khan E; I Khan M; Gul S
Pak J Pharm Sci; 2023 Sep; 36(5):1451-1456. PubMed ID: 37869921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
